373 related articles for article (PubMed ID: 27106243)
1. Metformin treatment status and abdominal aortic aneurysm disease progression.
Fujimura N; Xiong J; Kettler EB; Xuan H; Glover KJ; Mell MW; Xu B; Dalman RL
J Vasc Surg; 2016 Jul; 64(1):46-54.e8. PubMed ID: 27106243
[TBL] [Abstract][Full Text] [Related]
2. Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population.
Itoga NK; Rothenberg KA; Suarez P; Ho TV; Mell MW; Xu B; Curtin CM; Dalman RL
J Vasc Surg; 2019 Mar; 69(3):710-716.e3. PubMed ID: 30197158
[TBL] [Abstract][Full Text] [Related]
3. Metformin Prescription Associated with Reduced Abdominal Aortic Aneurysm Growth Rate and Reduced Chemokine Expression in a Swedish Cohort.
Unosson J; Wågsäter D; Bjarnegård N; De Basso R; Welander M; Mani K; Gottsäter A; Wanhainen A
Ann Vasc Surg; 2021 Jan; 70():425-433. PubMed ID: 32619497
[TBL] [Abstract][Full Text] [Related]
4. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
[TBL] [Abstract][Full Text] [Related]
5. Metformin prescription and aortic aneurysm: systematic review and meta-analysis.
Yu X; Jiang D; Wang J; Wang R; Chen T; Wang K; Durgahee MSA; Wei X; Cao S
Heart; 2019 Sep; 105(17):1351-1357. PubMed ID: 30936409
[TBL] [Abstract][Full Text] [Related]
6. Abdominal aortic aneurysm: a review on the role of oral antidiabetic drugs.
Ribeiro-Silva M; Oliveira-Pinto J; Mansilha A
Int Angiol; 2020 Aug; 39(4):330-340. PubMed ID: 32286765
[TBL] [Abstract][Full Text] [Related]
7. Association of Metformin and Abdominal Aortic Aneurysm Repair Outcomes.
Turowicz A; Kobecki J; Laskowska A; Wojciechowski J; Świątkowski F; Chabowski M
Ann Vasc Surg; 2021 Aug; 75():390-396. PubMed ID: 33826959
[TBL] [Abstract][Full Text] [Related]
8. Association between metformin prescription and growth rates of abdominal aortic aneurysms.
Golledge J; Moxon J; Pinchbeck J; Anderson G; Rowbotham S; Jenkins J; Bourke M; Bourke B; Dear A; Buckenham T; Jones R; Norman PE
Br J Surg; 2017 Oct; 104(11):1486-1493. PubMed ID: 28650557
[TBL] [Abstract][Full Text] [Related]
9. The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis.
Yuan Z; Heng Z; Lu Y; Wei J; Cai Z
Front Endocrinol (Lausanne); 2021; 12():721213. PubMed ID: 34394010
[TBL] [Abstract][Full Text] [Related]
10. Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes.
Taimour S; Zarrouk M; Holst J; Rosengren AH; Groop L; Nilsson PM; Gottsäter A
Scand Cardiovasc J; 2017 Aug; 51(4):202-206. PubMed ID: 28434285
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms.
Climent E; Benaiges D; Chillarón JJ; Flores-Le Roux JA; Pedro-Botet J
Clin Investig Arterioscler; 2018; 30(4):181-187. PubMed ID: 29580664
[TBL] [Abstract][Full Text] [Related]
12. Metformin does not reduce inflammation in diabetics with abdominal aortic aneurysm or at high risk of abdominal aortic aneurysm formation.
Wang SK; Green LA; Gutwein AR; Kenyon B; Motaganahalli RL; Fajardo A; Gupta AK; Murphy MP
Vascular; 2018 Dec; 26(6):608-614. PubMed ID: 29871586
[TBL] [Abstract][Full Text] [Related]
13. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
[TBL] [Abstract][Full Text] [Related]
14. Editor's Choice - Association Between Metformin Prescription and Abdominal Aortic Aneurysm Growth and Clinical Events: a Systematic Review and Meta-Analysis.
Thanigaimani S; Singh TP; Unosson J; Phie J; Moxon J; Wanhainen A; Golledge J
Eur J Vasc Endovasc Surg; 2021 Nov; 62(5):747-756. PubMed ID: 34556425
[TBL] [Abstract][Full Text] [Related]
15. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
16. Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
Kristensen KL; Pottegård A; Hallas J; Rasmussen LM; Lindholt JS
J Vasc Surg; 2017 Sep; 66(3):768-774.e2. PubMed ID: 28506478
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the Prolyl Hydroxylase Inhibitor JNJ Promotes Abdominal Aortic Aneurysm Progression in Diabetic Mice.
Guo J; Shoji T; Ge Y; Zheng X; Li Y; Zhao S; Ikezoe T; Liu S; Huang J; Wang W; Xu B; Dalman RL
Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):484-494. PubMed ID: 34872812
[TBL] [Abstract][Full Text] [Related]
18. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease and abdominal aortic aneurysm growth.
Takagi H; Umemoto T;
Vasc Med; 2016 Jun; 21(3):199-208. PubMed ID: 26842623
[TBL] [Abstract][Full Text] [Related]
20. A multi-locus genetic risk score for abdominal aortic aneurysm.
Ye Z; Austin E; Schaid DJ; Kullo IJ
Atherosclerosis; 2016 Mar; 246():274-9. PubMed ID: 26820802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
